Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Clarivate Plc: Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia
New approach enables broad, simple and affordable access to trusted scholarly content for learning and research LONDON, Feb. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading ...
Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new subscription-based ...